{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T09:52:35Z","timestamp":1761126755630},"reference-count":0,"publisher":"Croatian Medical Journals","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Croat Med J"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.3325\/cmj.2020.61.333","type":"journal-article","created":{"date-parts":[[2020,9,18]],"date-time":"2020-09-18T07:00:21Z","timestamp":1600412421000},"page":"333-337","source":"Crossref","is-referenced-by-count":6,"title":["Serum C-reactive protein to albumin ratio as a novel inflammation biomarker in psoriasis patients treated with adalimumab, ustekinumab, infliximab, and secukinumab: a retrospective study"],"prefix":"10.3325","volume":"61","author":[{"given":"Funda","family":"Tamer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emine","family":"Avc\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1858","container-title":["Croatian Medical Journal"],"original-title":[],"link":[{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7480757\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,21]],"date-time":"2020-09-21T07:00:19Z","timestamp":1600671619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7480757\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"URL":"https:\/\/doi.org\/10.3325\/cmj.2020.61.333","relation":{},"ISSN":["0353-9504","1332-8166"],"issn-type":[{"value":"0353-9504","type":"print"},{"value":"1332-8166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8]]}}}